PREPARATION AND CHARACTERIZATION OF [N-ALPHA-(4-AZIDO-2-NITROPHENYL)ALA1,TYR36]-PARATHYROID HORMONE RELATED PEPTIDE (1-36)AMIDE - A HIGH-AFFINITY, PARTIAL AGONIST HAVING HIGH CROSS-LINKING EFFICIENCY WITH ITS RECEPTOR ON ROS 17/2.8 CELLS

被引:10
作者
JUPPNER, H
ABOUSAMRA, AB
UNENO, S
KEUTMANN, HT
POTTS, JT
SEGRE, GV
机构
[1] Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, Fruit Street
关键词
D O I
10.1021/bi00482a001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis, purification, and structural analysis of the major compounds resulting from photoderivatization of [Tyr36]-parathyroid hormone related peptide (l-36)amide [[Tyr36]PTHrP(l-36)amide] are described. The reaction of the synthetic peptide with 4-fluoro-3-nitrophenyl azide under nonaqueous conditions yields three major products (peaks D-l, D-2, and G), which were purified to homogeneity by reverse-phase high-performance liquid chromatography. Subsequent amino acid analysis showed that the peptides of peaks D-l and G each lack one lysine residue, while the peptide in peak D-2 lacks one alanine residue, suggesting that these residues are chemically modified by photoderivatization. Sequence analysis of the photoderivatized peptides revealed that compounds D-l and G were derivatized on Lys13 and Lys11, respectively. Compound D-2 was N-blocked, indicating that this compound is derivatized on the α-amino function of Ala1. Both Lys residues of D-2 were quantitatively recovered upon sequencing after digestion with endoproteinase Glu-C. Compounds D-2 and G had apparent Kds of 1 × 10−9 M and 0.6 × 10−9 M, respectively, for their receptors on ROS 17/2.8 cells, which are identical with or similar to that of the underivatized [Tyr36]PTHrP(l-36)amide. Compound G had the same adenylate cyclase stimulating potency as the underivatized, synthetic [Tyr36]PTHrP(l-36)amide, whereas compound D-2 was only a partial agonist, having about 25% of the maximal cAMP production. Compound D-l, which is modified on Lys13, retained only 2-4% of its receptor binding affinity and biological activity relative to that of its parent compound. After radioiodination and incubation with ROS 17/2.8 cells in the dark, D-2 and G bound equivalently to the receptor protein (specific binding 18.0 ± 3.6% and 16.2 ± 1.3%, respectively), whereas [Nle8,Nϵ-(4-azido-2-nitrophenyl)Lys13,Nle18,Tyr34]bPTH(l-34)amide (NAP-NlePTH) and D-l bound less well (specific binding 5.6 ± 2.9% and 3.7 ± 2.4%, respectively), as was predicted from their dissociation constants. After photolysis and analysis by SDS-PAGE and autoradiography, labeling of the 80000-dalton receptor protein was approximately 5-10 times more efficient with D-2 than with G. This improved cross-linking efficiency of Ala1-photoderivatized [Tyr36]PTHrP(l-36)amide presumably reflects a steric advantage for this derivative, such as a closer proximity of the azide function at that position to the receptor protein, and suggests that this compound potentially is useful for receptor identification and isolation. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:6941 / 6946
页数:6
相关论文
共 24 条
[1]   STIMULATION OF OVINE PLACENTAL CALCIUM-TRANSPORT BY PURIFIED NATURAL AND RECOMBINANT PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) PREPARATIONS [J].
ABBAS, SK ;
PICKARD, DW ;
RODDA, CP ;
HEATH, JA ;
HAMMONDS, RG ;
WOOD, WI ;
CAPLE, IW ;
MARTIN, TJ ;
CARE, AD .
QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1989, 74 (04) :549-552
[2]  
ABOUSAMRA AB, 1987, J BIOL CHEM, V262, P1129
[3]   HIGH-LEVELS OF A PARATHYROID HORMONE-LIKE PROTEIN IN MILK [J].
BUDAYR, AA ;
HALLORAN, BP ;
KING, JC ;
DIEP, D ;
NISSENSON, RA ;
STREWLER, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7183-7185
[4]   AVIAN (CHICKEN) PARATHYROID-HORMONE - SYNTHESIS AND COMPARATIVE BIOLOGICAL EVALUATION OF THE 1-34 FRAGMENT [J].
CAULFIELD, MP ;
LEVY, JJ ;
MCKEE, RL ;
GOLDMAN, ME ;
DEHAVEN, PA ;
REAGAN, JE ;
HEANEY, L ;
NUTT, RF ;
WINQUIST, RJ ;
RUSSELL, J ;
SHERWOOD, LM ;
ROSENBLATT, M .
ENDOCRINOLOGY, 1988, 123 (06) :2949-2951
[5]  
GOLTZMANN D, 1975, J BIOL CHEM, V250, P3199
[6]  
GUILLEMETTE G, 1986, MOL PHARMACOL, V30, P544
[7]   SIMILARITY OF SYNTHETIC PEPTIDE FROM HUMAN-TUMOR TO PARATHYROID-HORMONE INVIVO AND INVITRO [J].
HORIUCHI, N ;
CAULFIELD, MP ;
FISHER, JE ;
GOLDMAN, ME ;
MCKEE, RL ;
REAGAN, JE ;
LEVY, JJ ;
NUTT, RF ;
RODAN, SB ;
SCHOFIELD, TL ;
CLEMENS, TL ;
ROSENBLATT, M .
SCIENCE, 1987, 238 (4833) :1566-1568
[8]  
JUPPNER H, 1988, J BIOL CHEM, V263, P8557
[9]   STRUCTURAL-PROPERTIES OF THE RENAL PARATHYROID-HORMONE RECEPTOR - HYDRODYNAMIC ANALYSIS AND PROTEASE SENSITIVITY [J].
KARPF, DB ;
ARNAUD, CD ;
BAMBINO, T ;
DUFFY, D ;
KING, KL ;
WINER, J ;
NISSENSON, RA .
ENDOCRINOLOGY, 1988, 123 (06) :2611-2620
[10]   PARATHYROID HORMONE-RELATED PROTEIN OF MALIGNANCY - ACTIVE SYNTHETIC FRAGMENTS [J].
KEMP, BE ;
MOSELEY, JM ;
RODDA, CP ;
EBELING, PR ;
WETTENHALL, REH ;
STAPLETON, D ;
DIEFENBACHJAGGER, H ;
URE, F ;
MICHELANGELI, VP ;
SIMMONS, HA ;
RAISZ, LG ;
MARTIN, TJ .
SCIENCE, 1987, 238 (4833) :1568-1570